Citation Impact
Citing Papers
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
2015
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
MYC regulates the antitumor immune response through CD47 and PD-L1
2016 Science
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Meta-hallmarks of aging and cancer
2023
2016
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
2017
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
2015
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
2019
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Hepatocellular carcinoma
2018 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Shared and Distinct Functions of Type I and Type III Interferons
2019
Purinergic regulation of the immune system
2016
Nasopharyngeal carcinoma
2019 Standout
Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view
2021
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
2017
Immunogenic cell death in cancer and infectious disease
2016 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Immunological landscape and immunotherapy of hepatocellular carcinoma
2015
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
2016
Next generation immune-checkpoints for cancer therapy
2018
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
2020
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Inflammation and immune surveillance in cancer
2011
Engineering interferons and interleukins for cancer immunotherapy
2022
Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities
2014
The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells
2018
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
2015
The microbiome and cancer
2013
Using immunotherapy to boost the abscopal effect
2018
Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor
2015
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
2015
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
2019
Nutrition, inflammation and cancer
2017
Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
2015
Therapeutic T cell engineering
2017 Nature
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Head and Neck Cancer
2020 Standout
CD73: A potential biomarker for anti-PD-1 therapy
2015
New insights into the role of EMT in tumor immune escape
2017
Immunological mechanisms of the antitumor effects of supplemental oxygenation
2015
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
2016
Chimeric Antigen Receptor Therapy
2018 Standout
TISIDB: an integrated repository portal for tumor–immune system interactions
2019 Standout
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
2017
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
2018
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
2016
Neoantigen landscape dynamics during human melanoma–T cell interactions
2016 Nature
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
2015
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Metronomic chemotherapy and immunotherapy in cancer treatment
2017
Works of Deepak Mittal being referenced
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
2016
NK cells require IL-28R for optimal in vivo activity
2015
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
2016
TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells
2010
New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape
2014
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
2014
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
2014